Literature DB >> 210238

Cytomegalovirus infection in guinea pigs. I. Viremia during acute primary and chronic persistent infection.

G D Hsiung, Y C Choi, F Bia.   

Abstract

Studies on the pathogenesis of cytomegalovirus (CMV) infection in guinea pigs have revealed two distinct phases of infection, without any signs of clinical disease. During acute primary infection, viremia was easily demonstrated and infectious virus was recovered from various tissues, including lung, spleen, and kidney, of the infected animal two to 10 days after inoculation. Chronic persistent infection was readily established thereafter. In animals with chronic persistent infection with high levels of circulating antibody, infectious virus was consistently isolated from the salivary gland and pancreas. Evidence of CMV in the blood of the persistently infected animals was detected only occasionally and only when a highly sensitive method and/or a large inoculum was used. However, the anticoagulant heparin was found to inactivate CMV significantly during collection of blood. These data suggest that CMV was indeed circulating in the blood of apparently health but persistently infected animals for prolonged periods. Such infected blood could conceivably be the source of CMV infection when large quantities of blood are given to susceptible recipients.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 210238     DOI: 10.1093/infdis/138.2.191

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

Review 1.  Animal cytomegaloviruses.

Authors:  J Staczek
Journal:  Microbiol Rev       Date:  1990-09

Review 2.  Viruses of guinea pigs: considerations for biomedical research.

Authors:  G D Hsiung; F J Bia; C K Fong
Journal:  Microbiol Rev       Date:  1980-09

3.  Acquired chemotactic inhibitors during infection with guinea pig cytomegalovirus.

Authors:  R Tannous; M G Myers
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

4.  Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses.

Authors:  V R Freitas; D F Smee; M Chernow; R Boehme; T R Matthews
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

5.  Guinea pig cytomegalovirus immediate-early transcription.

Authors:  C Y Yin; M Gao; H C Isom
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

6.  Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?

Authors:  Mark R Schleiss
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

7.  New endogenous herpesvirus of guinea pigs: biological and molecular characterization.

Authors:  F J Bia; W C Summers; C K Fong; G D Hsiung
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

8.  Neutrophil response and function during acute cytomegalovirus infection in guinea pigs.

Authors:  E L Yourtee; F J Bia; B P Griffith; R K Root
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

9.  Characterization of the guinea pig cytomegalovirus genome by molecular cloning and physical mapping.

Authors:  M Gao; H C Isom
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

10.  Characterization of guinea pig cytomegalovirus DNA.

Authors:  H C Isom; M Gao; B Wigdahl
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.